Alyeska Investment Group, L.P. Ars Pharmaceuticals, Inc. Comm Transaction History
Alyeska Investment Group, L.P.
- $25 Billion
- Q4 2024
A detailed history of Alyeska Investment Group, L.P. transactions in Ars Pharmaceuticals, Inc. Comm stock. As of the latest transaction made, Alyeska Investment Group, L.P. holds 1,253,724 shares of SPRY stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,253,724
Previous 125,000
902.98%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%